Of particular note, SMAD4 deficiency accelerated transformation in EGFR-wildtype, TP53-deficient NSCLC cells, suggesting that alternative molecular routes can drive neuroendocrine differentiation in the absence of EGFR mutation. Here, TP53 is linked to non-small cell lung carcinoma.